Girls don't have to get a nine-valent vaccine. Bivalent and tetravalent vaccines are enough. The bivalent vaccine can prevent HPV 16 and 18, and the tetravalent vaccine can prevent HPV6, 1 1, 16 and 18. Bivalent and tetravalent vaccines can prevent 70% of cervical cancer, and nine-valent vaccines can prevent about 90% of cervical cancer.
As can be seen from the figure, the difference between nine-valence, two-valence and four-valence is that nine-valence can prevent cervical cancer with a relatively high probability, and can additionally prevent diseases such as acute eczema.
? By age, women aged 9-45 can be vaccinated with bivalent vaccine, women aged 20-45 can be vaccinated with tetravalent vaccine, and women aged 16-26 can be vaccinated with nonavalent vaccine.
However, do you have to get a nine-valent HPV vaccine? Next, let's take a look. Does the HPV vaccine cost nine? That's not true.
The final choice of vaccine needs to be considered from many aspects such as price, age and convenience. If conditions permit, nine-valent vaccine is the best choice.
If there is no nine-valent vaccine, or if the nine-valent vaccine is too old, you can get bivalent and tetravalent vaccines. These two vaccines can cover the two most common types of human papillomavirus in cervical cancer: 16 and 18, effectively reducing the chance of cervical cancer. In theory, bivalent and tetravalent vaccines can reduce the risk of cervical cancer by about 70%.
? Therefore, HPV vaccine does not have to be priced at nine. According to the individual's actual situation, you can make an appointment for several prices, and there is no need to blindly pursue the nine-valent vaccine.
Therefore, after vaccination with human papillomavirus vaccine, cervical cancer screening is still needed on a regular basis.
Benefits of human papillomavirus vaccination;
? At present, the human papillomavirus vaccines on the market are all preventive vaccines, which can induce the body to produce specific antibodies, including bivalent, tetravalent and nonavalent, and the inoculation type can be determined according to the age and economic situation. It is reported that bivalent and tetravalent vaccines can prevent 70% of cervical cancer, and nine-valent vaccines can prevent about 90% of cervical cancer. Studies have shown that HPV vaccine also has a good preventive effect on genital warts, anal cancer's disease and vaginal cancer. It should be noted that HPV vaccine can only prevent cervical cancer by reducing the infection rate of human papillomavirus, but it can't 100% prevent cervical cancer.